Eileen L. Whiteman
- Molecular Biology top 10%
- Cell Biology top 5%
- Physiology top 10%
- Epidemiology top 10%
- Surgery
- Co-authors
- Morris J. BirnbaumHan ChoMitchell A. LazarClaire M. SteppanJuan WangBen MargolisBenjamin MargolisLiu C
- Topics
- Metabolism, Diabetes, and Cancer (6 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)Hippo pathway signaling and YAP/TAZ (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Eileen L. Whiteman
17 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.1k
- Cell Biology 443
- Physiology 328
- Epidemiology 261
- Surgery 258
Countries citing papers authored by Eileen L. Whiteman
This map shows the geographic impact of Eileen L. Whiteman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen L. Whiteman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen L. Whiteman more than expected).
Fields of papers citing papers by Eileen L. Whiteman
This network shows the impact of papers produced by Eileen L. Whiteman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen L. Whiteman. The network helps show where Eileen L. Whiteman may publish in the future.
Co-authorship network of co-authors of Eileen L. Whiteman
This figure shows the co-authorship network connecting the top 25 collaborators of Eileen L. Whiteman. A scholar is included among the top collaborators of Eileen L. Whiteman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen L. Whiteman. Eileen L. Whiteman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 95 | |
| 2 | 14 | |
| 3 | 57 | |
| 4 | 114 | |
| 5 | 152 | |
| 6 | 42 | |
| 7 | 36 | |
| 8 | 79 | |
| 9 | 225 | |
| 10 | 2 | |
| 11 | 43 | |
| 12 | Role of Akt/protein kinase B in metabolismbreakdown → | 553 |
| 13 | 56 | |
| 14 | 91 | |
| 15 | 54 | |
| 16 | 82 | |
| 17 | 56 |
About Eileen L. Whiteman
Eileen L. Whiteman is a scholar working on Cell Biology, Molecular Biology and Neurology, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). The work is most often cited by research in Cell Biology (443 citations), Molecular Biology (1.1k citations) and Endocrine and Autonomic Systems (112 citations). Eileen L. Whiteman has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Morris J. Birnbaum, Han Cho, Mitchell A. Lazar, Claire M. Steppan, Juan Wang, Ben Margolis, Benjamin Margolis, Liu C, Eric R. Fearon and Scott A. Summers. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.